Systemic metabolic reprogramming within 24 h predicts delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

Read full text Summarise with VIRAT
Authors: Le Guan, Chudi Feng, Xu Wang, Bin Wang, Pan Li, Zhuoyu Yang, Xinyu Zhang, Guoliang Qian, Zigang Yuan
Cited by: 0
References: 42

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Delayed cerebral ischemia (DCI) remains a major determinant of poor outcomes after aneurysmal subarachnoid hemorrhage (aSAH), yet early risk stratification is challenging. Methods A retrospective cohort of 44 aSAH patients was analyzed (DCI, n = 22; non-DCI, n = 22). Serum collected within 24 h of admission underwent untargeted liquid chromatography–tandem mass spectrometry metabolomics. Between-group separation was evaluated using supervised multivariate modeling with permutation testing. Differential metabolites were identified using a combined multivariate and univariate strategy (two-sided P < 0.05), followed by pathway enrichment analysis. Independent clinical predictors were assessed using multivariate logistic regression, and aneurysm morphology was quantified on admission CT angiography using radiomics-derived parameters. Results The DCI group was older, had a higher proportion of females, worse admission neurological status, higher vasospasm incidence, and lower hemoglobin. Vasospasm and age were independent predictors. Aneurysm morphological parameters showed no between-group differences. Metabolic profiles showed clear separation, supported by permutation testing ( R 2 = 0.6485; Q 2 intercept = −0.4173). A total of 110 differential metabolites were identified (39 upregulated and 71 downregulated in DCI). Representative changes included increased sphinganine, 2-octenoylcarnitine, guanidoacetic acid, and 5-aminopentanoic acid, with decreased lysophosphatidylcholine 16:0, lysophosphatidylethanolamine 16:0, xanthine, and dehydroepiandrosterone sulfate. Enrichment highlighted coordinated alterations in energy-related, amino-acid, and nucleotide-related pathways. Conclusion Early serum metabolomics within 24 h after aSAH revealed a DCI-associated systemic metabolic signature, supporting the identification of exploratory serum metabolic features associated with DCI in a Chinese cohort, which may inform future biomarker development following targeted validation.

Fields of Study & Subjects

Intracranial Aneurysms: Treatment and Complications Intracerebral and Subarachnoid Hemorrhage Research Metabolomics and Mass Spectrometry Studies

Publication details

Journal / source
Frontiers in Neuroscience
Volume
20
Pages
1792615–1792615
Publication date
26 March 2026
Language
EN